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What is health? 
State of complex physical, mental and social well-being 
and not merely the absence of disease or infirmity  
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Where medicine and engineering meet 
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▲ Some	  molecular	  tests	  can	  be	  done	  in	  real	  2me	  	  
▽ Eﬃcient	  and	  lower	  cost	  for	  rou2ne	  care	  
▽ Some	  diagnos2cs	  require	  mul2ple	  tests	  
	  
▲ Emergency	  situa2ons	  require	  real-­‐2me	  measures	  
▽ Pa2ent’s	  ﬂuids	  are	  oQen	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▽ Local	  tests	  and	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  diagnosis	  
Point of care 
Tele-medicine:  
Monitoring chronic patients 
▲ Non-­‐invasive	  monitors	  	  
▽ Heart	  rate,	  SpO2,	  blood	  pressure	  
▲ Invasive	  monitors:	  
▽ Metabolites:	  glucose,	  lactate,	  cholesterol	  








Prototype for human implant [EPFL] Muti-sensor for lab animals [EPFL] GLUCOSE SENSOR [SenseonicsTM ] 
Acetaminophen 
Tele-medicine 
Remote ultrasound diagnosis 
▲ Ultrasound	  (US)	  imaging	  is	  widely	  used	  
▽ Standard	  US	  needs	  a	  radiologist	  to	  operate	  the	  probe	  
▽ Hard	  to	  use	  in	  emergencies	  and	  in	  remote	  areas	  
▲ 3D	  	  Ultrasound	  can	  obviate	  this	  problem	  
▽ 3D	  volumes	  can	  acquired	  by	  non-­‐specialist	  
▽ Then	  transmiBed	  to	  medical	  provider	  
▽ Then	  sec2oned	  and	  analyzed	  remotely	  
▲ Current	  3D	  systems	  are	  bulky,	  	  
expensive	  and	  power-­‐hungry	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Tele-medicine 
Remote ultrasound diagnosis 
▲ Design	  portable	  3D	  US	  system	  	  
▽ Lightweight,	  low-­‐power,	  wirelessly	  connected	  
▲ Tight	  integra2on	  of	  probe	  and	  beamforming	  electronics	  
▽ High	  processing	  power	  
▽ Heat	  removal	  
	  
New	  2D	  probes	  for	  
3D	  image	  acquisi2on	  
New	  low-­‐power,	  low-­‐
cost	  hardware	  design	  
Image	  reconstruc2on,	  
rota2on	  &	  sec2oning	  
[Courtesy:	  Benini,	  ETHZ]	  
Patient care support systems 
▲ Drug	  administra2on	  decision	  support	  systems	  
▽ 	  Drug	  selec2on,	  dosage	  and	  2ming	  
▲ Data	  acquisi2on	  by	  integrated	  sensors	  
▽ 	  Con2nuous	  and	  real-­‐2me	  
▲ Applicable	  to	  hospital	  care	  





Smart drug administration 
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▽ Electrical,	  mechanical,	  op2cal	  
▲ Fluidics	  and	  transducers	  
▽ Micro	  tubes,	  valves,	  pumps	  
▲ Data	  acquisi2on	  electronics	  






▽ Glucose,	  lactate,	  cholesterol…	  
▲ Exogenous	  metabolites:	  
▽ Drugs,	  e.g.,	  an2-­‐inﬂammatory,	  chemotherapy,	  …	  
▲ Biomarkers:	  
▽ Tumor	  growth	  factors	  
▲ DNA,	  RNA	  
▲ Ions	  (K,	  Na)	  
▲ …	  
Biosensing targets 
Integrated sensors sensitivity and range 





Detec3on	  limit	  	  
(S/N	  =	  3σ)	  	  	  	  (µM) 
Glucose 27.7 0.5	  –	  4 73 
Lactate 40.1 0.5	  –	  2.5 28 
Glutamate 25.5 0.5	  –	  2 195 
ATP 3.42 0.5	  –	  1.4 208 
[Courtesy	  Carrara,	  EPFL]	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FETs: electronic transducers for 
chemi/bio-recognition events 
▲  Surface	  poten2al	  changes	  as	  a	  
func2on	  of	  the	  ion	  concentra2on:	  
•  pH	  sensing	  (H+	  ions)	  
•  Other	  ions	  (membrane)	  
MOSFET	  
ISFET	  
P. Bergveld et al., IEEE TBME 17(1), 1970	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Bio-FETs 
Relevance of SiNWs 











































1.	  Nano	  size	  
•  Best	  interface	  to	  proteins	  	  
2.	  Surface-­‐to-­‐volume	  ra2o	  
•  Larger	  interac2on	  area	  
•  Charge	  conﬁnement	  
SENSITIVITY	  




Reprinted from Curreli et al., IEEE TNANO 7, 2008	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Curr nt	  decrease	  
Reprinted from Patolsky et al., PNAS 101(39), 2004	  




	   	  
Vds	  
Vbg	  
Voltage-gap SiNW biosensors 
Bare NWs
NWs functionalized with Ab














The	  VoG	  parameter	  
Puppo et al. BIOCAS 2014	  
Zhang,	  G.,	  et	  al.,	  Nature	  Nanotech.,	  2005,	  23(10),	  1294-­‐1301	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Applications of Bio SiNW-FETs 
Cancer	  markers	  detec2on	  
Gao,	  A.,	  et	  al.,	  Nano	  LeB.	  2011,	  11,	  3974–3978	  
Stern,	  E.,	  et	  al.,	  Nature,	  2007,	  445,	  519-­‐522	  
DNA	  detec2on	  
Small	  molecule	  detec2on	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▲ SiNWs	  realized	  by	  DRIE	  and	  bio-­‐func2onaliza2on	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(a)Nanostructuring (Uric Acid) 
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Nanocarbon yieldBare




[Taurino, Nano Letters, 2014]






Nanostructuring: Au-Pt Nanoferns 
200 nm 200 nm
Pt tetravalent Pt divalent 
Au-Pt nanoferns 
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Monolithic and TSV-based integration 
[Schienle	  et	  al.,	  JSSC	  2004]	  
[Temiz	  et	  al.,	  Lab	  on	  Chip	  2012]	  
	  
Disposable biosensing layer: In molecular sensing applications, suit-
able surface preparation procedures are required on the active area.
Although CMOS integration is desirable for these applications,
surface chemistry steps may degrade the protection layers (such as the
layers protecting the wirebonds), and may damage the sensitive elec-
tronics. Moreover, even after intensive cleaning, it is usually difficult
to revert the sensor to the initial state. This limits the repeatability and
reliability of the measurements. Furthermore, especially in clinical diag-
nostic applications, it is preferred to use the disposable sensor to avoid
any possible cross-contamination. One solution is to dispose of the com-
plete system after each measurement. Using the active-electronic bio-
sensor only once can be acceptable for research purposes, but it will
not be very attractive in the market due to economic reasons, especially
for a 3D integrated chip stack. The other solution is to use the active
electronics repeatedly and substitute the used biosensing area with a
new one after each measurement. Therefore, in this Letter, we propose
a new system comprising vertically stacked electronics and a layer of
biosensing sites atop, which can be attached and detached in the field
[16]. Fig. 3 shows an illustration of the proposed 3D integrated lab-
on-a-chip.
analogue front-end (90nm–600nm)















Fig. 3 Illustration of 3D integrated biosensor with detachable and dispos-
able biosensing layer [16]
This approach combines the advantages of both active-electronic and
passive-electronic (disposable) biochips in one system. The top sensing
layer is temporarily attached to the analogue interface circuit through
vertical interconnections. These allow the fabrication of high density
multi-target arrays since they solve the horizontal signal routing
problem encountered in disposable biosensors. In addition, since the
interface electronics is in the direct neighbourhood of the array, weak
sensor-signals can be amplified while being minimally affected by the
parasitic effects, thus leading to considerable improvement in sensitivity
and signal integrity. Analogue outputs are converted to digital signals
through on-chip analogue-to-digital converters and processed by dedi-
cated digital electronics. Hence, the signal processing required to
solve complex algorithms for target identification can be accomplished
on the system. This technology also allows employing different
measurement techniques (cyclic voltammetry, impedance measurement
etc.) by simply replacing the top sensing layer and configuring the ana-
logue front-end accordingly.
In addition to the electrical improvements, the proposed system has
some potential advantages in terms of fabrication and packaging.
First, the fabrication process for the replaceable top biosensing layer
and the CMOS are completely decoupled; for example, we can use
non-CMOS compatible processes and materials for the sensors. This
eliminates some of the difficulties encountered in post-CMOS proces-
sing of integrated sensors. Moreover, temperature control is extremely
important for certain biosensing applications. In active-electronic bio-
sensors for example, the temperature may vary due to CMOS power con-
sumption. In the disposable layer approach, the temperature coupling
between the CMOS and the sensing part can be reduced to some
extent. Last but not least, protecting the wirebonds from the solutions
is a serious packaging problem in CMOS-based sensors. Since we
replace the wirebonds with the TSVs and protect the CMOS chip with
the silicon housing, the CMOS chip is not exposed to the liquids
any more.
To demonstrate the feasibility of the system, we are developing test
vehicles through standard microfabrication processes. In the first gener-
ation, which involves rigid micro-contacts, the interconnections are fab-
ricated by silicon etching and electroplating. First, the silicon is etched
by DRIE to form the vias. Then, the contact openings are fabricated
by KOH etching, where the via sidewalls are protected by a thermally-
grown oxide layer. Following the etching steps, the openings are filled
with Ni electroplating. The backside of the wafer is then etched by
DRIE to reach the electroplated micro-contacts and to have an
opening where the CMOS stack can fit inside. Fig. 4 shows the SEM
photos of the front-side of the wafer after the etching steps, and back-
side of the wafer after Ni electroplating and back-side silicon etching.
These types of rigid contacts, however, do not offer the spring function.
Therefore, electrical contact is not always guaranteed for all connections
owing to possible height differences. Also, rigid contacts may give an
erosion problem on the CMOS pads, which degrades the reusability of













Fig. 4 SEM photos of front-side of wafer after via and contact opening
etching steps (left), and back-side of wafer after Ni electroplating and Si
DRIE (right) [16]
Fig. 5 shows an illustration of the disposable biosensing layer with the
spring contacts. For many years, such contacts have been employed for
MEMS probe cards for IC testing [17, 18]. Recently, the feasibility of
the spring contacts in CMOS-biosensor integration has also been
demonstrated [19]. In our approach, we use special geometries which
enable us to pattern the contacts aligned to {111} crystal planes. A
very conformal Parylene deposition is employed to form the springs
and to close the openings. The electrical connections between the elec-
trodes and the contacts are achieved by sputtering a metal film through
the openings. The wafer backside is then etched by DRIE to form a
silicon frame for the CMOS chip placement. Finally, the springs are
released by maskless Parylene etching from the backside. Fig. 6
shows an SEM photo of the contacts after backside silicon etching














Fig. 5 Illustration of biosensing layer with spring contacts
Parylene
silicon 20 mm
Fig. 6 SEM photo of spring contacts (wafer backside) before anisotropic
Parylene etching to release springs
Finally, since the whole idea is based on the replacement of the
sensing chip on top of the electronics, the alignment accuracy is of
central importance. For a compact and low-cost biosensing system, the
placement technique should not employ any expensive tool and
should be done easily in the field. In this sense, we propose to use the
silicon frame for the mechanical alignment. Test structures are fabricated
to statistically analyse the alignment accuracy in manual pick and place-
ment of diced chips into the silicon frames [15]. Fig. 7 shows the histo-
gram for the maximum alignment error in either direction for each chip.
The measurements demonstrate that the average alignment error is
5.5 mm, which is small enough for the electrode dimensions we target.
Electronics Letters Dec. 2011 – Special Supplement: Semiconductors in Personalised Medicine doi: 10.1049/el.2011.2683 S23
[Temiz	  et	  al.,	  El	  LeBers	  2011]	  
▲ Electrical	  biosensors	  are	  available	  for	  various	  
substances	  
▽ S2ll	  limited	  use	  because	  of	  predictability	  
▲ Strong	  poten2al	  for	  future	  growth	  
▽ Integra2on	  with	  front-­‐end	  electronics	  
▽ Parallel	  redundant	  measures	  
▲ Various	  nano-­‐materials	  and	  technologies	  can	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▽ Low	  noise	  (driQ)	  
▽ Low	  power	  (implants)	  
	  
Circuits and design 
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▲ Mul2ple	  sensor	  integra2on	  on	  silicon	  
▽ Electronic	  resource	  sharing	  
▽ Various	  dynamic	  ranges	  
▲ Reducing	  Non-­‐Recurring	  Engineering	  (NRE)	  	  costs	  
▽ Modular	  electrode	  and	  interface	  physical	  design	  
▽ Standard-­‐cell	  like	  design	  
▲ Several	  families	  of	  medical	  tests	  where	  analyses	  can	  
be	  done	  by	  sensors	  with	  similar	  structures	  
▽ Possibly	  various	  current	  values	  and	  ranges	  of	  interest	  
▽ Readout	  circuit	  sharing/mul2plexing	  
Programmable sensing platform 
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▲ Sensor	  array	  platorm	  where	  targets	  are	  chosen	  
aQer	  silicon	  fabrica2on	  
▽ FPGAs	  are	  reminiscent	  of	  FPGAs	  
▽ Maximal	  ﬂexibility	  in	  applica2on	  
▲ Programming	  FPSAs	  
▽ Selec2ng	  sensing	  mediators	  in	  last	  fabrica2on	  step	  
▽ Providing	  sensing	  mediators	  via	  microﬂuidics	  
▽ Selec2ng	  sensing	  sites	  on	  the	  ﬁeld	  by	  programming	  
	  
Field-programmable sensing array 
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▲ Biosensor	  integra2on	  enables	  
▽ Mul2ple/simultaneous	  	  readout	  of	  	  
Ø Same	  target	  
Ø Diﬀerent	  targets	  
▲ Data	  elabora2on	  to	  enhance	  result	  quality	  
▽ Reproducibility	  	  
▽ False	  posi2ve/nega2ve	  
▲ Majority	  and	  threshold	  logic	  play	  an	  important	  
role	  in	  data	  processing	  
▽ In	  situ	  data	  processing	  
Sensor data analysis 
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▲ Design	  tools	  for	  sensor	  subsystems	  
▽ Current	  DA	  tools	  plus	  sensor	  design	  support	  
▲ On-­‐line	  support	  tools	  
▽ Map	  clinical	  requirements	  to	  speciﬁc	  bio	  tests	  
▽ Conﬁgure	  system	  for	  sensing	  opera2on	  
▲ Conformity	  check	  
▲ Redundant	  checks	  can	  increase	  reliability	  	  
SW tools for design and operation 
▲ Co-­‐design	  of	  electronics	  and	  sensing	  is	  crucial	  
▽ Achieve	  low-­‐power	  consump2on	  
▽ Achieve	  small	  footprint	  
▲ Platorm-­‐based	  design	  
▽ Modularity	  of	  design	  can	  reduce	  NREs	  
▲ Electronic	  technology	  can	  be	  extended	  upwards	  
▽ Monolithic	  integra2on	  





▽ Trends	  in	  Engineering	  and	  Medicine	  
▽ Examples	  from	  the	  medical	  prac2ce	  
▲ Cyber-­‐medical	  systems	  
▽ Sensors	  




u  Drug dosage according to the individual 
pharmacokinetic profile 
Therapeutic Drug Monitoring (TDM) 
44	   J. Hiemke / European journal of clinical pharmacology 64.2 (2008): 159-166.  
Drug concentration in blood 
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Smart drug administration 
▲ Policy	  design:	  
▽ Determine	  the	  sequence	  and	  dose	  of	  the	  drug	  
▲ Predic2ve	  models:	  
▽ Extract	  system	  state	  from	  external	  parameters	  
▲ Close-­‐loop	  models:	  
▽ Measure	  system	  state:	  drug	  concentra2on	  
▲ Objec2ve:	  
▽ Minimize	  drug	  dose/administra2on	  	  




▽ The	  system	  must	  perform	  its	  func2on	  in	  any	  condi2on	  
▲ Security:	  
▽ No	  medical	  informa2on	  leaking	  to	  other	  par2es	  
▽ No	  access	  from	  non-­‐authorized	  sources	  
▲ Safety:	  
▽ Under	  no	  condi2on	  the	  health-­‐device	  can	  be	  a	  threat	  
▽ Safety	  must	  be	  guaranteed	  for	  both	  pa2ent	  and	  operator	  
▲ Dependability:	  
▽ All	  devices	  must	  work	  long	  2me	  in	  possibly	  harsh	  condi2on	  
▽ Graceful	  degrada2on	  mechanisms	  
(c) Giovanni De Micheli  
48	  
▲ Diagnos2c	  systems	  
▽ Accuracy,	  linearity,	  limit	  of	  detec2on	  
▲ Drug	  administra2on	  decision	  support	  systems	  
▽ Decisions	  based	  on	  acquired	  data	  must	  be	  correct	  
▽ Life-­‐cri2cal	  systems	  
Correctness 
W. You,et al. BioNanoScience, 2013 
▲ Verify	  that	  a	  therapeu2c	  protocol	  is	  
▽ Consistent	  
▽ Complete	  
▲ Verify	  that	  a	  drug	  administra2on	  control	  unit	  
is	  a	  correct	  implementa6on	  of	  the	  protocol	  
▽ Model	  checking	  
The verification problem 
49	  
Formal model of Imatinib protocol 
50	   A. Simalastar,et al. International Journal on Artificial Intelligence Tools, vol. 23, no. 3, 2014 
▲ Very	  few	  protocols	  have	  a	  formal	  descrip2on	  
▽ Corner	  cases	  are	  hazardous	  for	  pa2ents	  
▲ Personaliza2on	  of	  drug	  dosage	  is	  important	  
▽ But	  s2ll	  used	  in	  few	  cases	  
▲ Modeling	  human	  body	  reac2on	  is	  cri2cal	  





▽ Trends	  in	  Engineering	  and	  Medicine	  
▽ Examples	  from	  the	  medical	  prac2ce	  
▲ Cyber-­‐medical	  systems	  
▽ Sensors	  





▲ New	  electronic	  health	  systems	  and	  services	  will	  be	  
enabled	  by	  advances	  in	  biology	  and	  medicine,	  
in	  combina2on	  with	  progress	  in	  electronics	  	  
▲ The	  ra2onaliza2on	  of	  health	  care	  will	  provide	  
advanced	  care	  to	  a	  broader	  audience	  at	  lower	  cost	  
▲ Human	  factors	  will	  s2ll	  be	  central	  to	  decisions	  in	  
medicine	  	  -­‐	  decision	  support	  will	  be	  automated	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Thank you 
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